Bellevue Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $204M | Sell |
|
|||||
|
2024
Q3 | $182M | Buy |
|
|||||
|
2024
Q2 | $169M | Sell |
|
|||||
|
2024
Q1 | $195M | Sell |
|
|||||
|
2023
Q4 | $220M | Sell |
|
|||||
|
2023
Q3 | $165M | Sell |
|
|||||
|
2023
Q2 | $203M | Sell |
|
|||||
|
2023
Q1 | $177M | Sell |
|
|||||
|
2022
Q4 | $177M | Buy |
|
|||||
|
2022
Q3 | $155M | Sell |
|
|||||
|
2022
Q2 | $191M | Sell |
|
|||||
|
2022
Q1 | $210M | Sell |
|
|||||
|
2021
Q4 | $190M | Sell |
|
|||||
|
2021
Q3 | $141M | Buy |
|
|||||
|
2021
Q2 | $147M | Sell |
|
|||||
|
2021
Q1 | $124M | Hold |
|
|||||
|
2020
Q4 | $116M | Buy |
|
|||||
|
2020
Q3 | $91.9M | Sell |
|
|||||
|
2020
Q2 | $97M | Buy |
|
|||||
|
2020
Q1 | $57.4M | Buy |
|
|||||
|
2019
Q4 | $81.2M | Sell |
|
|||||
|
2019
Q3 | $19.3M | Buy |
|
|||||
|
2019
Q2 | $29.1M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $599K | Sell |
|
|||||
|
2018
Q3 | $1.19M | Sell |
|
|||||
|
2018
Q2 | $1.41M | Sell |
|
|||||
|
2018
Q1 | $1.92M | Sell |
|
|||||
|
2017
Q4 | $1.34M | Buy |
|
|||||
|
2017
Q3 | $631K | Hold |
|
|||||
|
2017
Q2 | $497K | Buy |
|